Cantimer’s sensor platform represents a convergence of micro–electromechanical systems (MEMS) technology and advanced polymer science. Each sensor incorporates a silicon microcantilever (dimensions 300µ by 50µ by 3µ) embedded in a tiny droplet (~0.1µL) of an agent-selective, proprietary polymer. When exposed to the chemical or biological agent for which it is designed, the polymer changes volume, creating movement in the microcantiliver that generates a resistance change that can be measured. Microcantilever strains of only a few Ångstroms are measurable, enabling potential detection sensitivities of just a few molecules.
The simplicity and elegance of Cantimer’s approach facilitates the development of small, portable and reusable, rapid-response detection and measurement systems. The Company has already demonstrated proof of principle for the rapid, convenient and quantitative detection and measurement of viruses, single strand DNA, proteins, pH and a variety of biomarkers, including sodium, potassium, glucose, urea and ethanol. The Company’s platform is flexible, convenient, easy to use, and requires little or no capital outlay for end–users. To date, the Company has had four five U.S. patents issued, with fourfive additional U.S. patents (and international applications) pending.
Cantimer is interested in exploiting its broad sensor development capabilities in the development of proprietary sensors for partners. For additional information, please contact:
Ray Stewart, Ph.D.
Chief Technology Officer
rstewart@cantimer.com
(650) 474-0500, x302